Article
Antibodies raised to short synthetic peptides with sequences derived from HIV-1 SF2 gp120 can both neutralize and enhance HIV-1 SF13: a later variant isolated from the same host.
Journal of medical virology - 1 Jul 2001
Davis D, Trischmann H, Stephens D M, Lachmann P J
Abstract excerpt
HIV-1 SF13 emerged in a patient with immunity to HIV-1 SF2. This study determined the effect of antibodies raised to HIV-1 SF2 on the replication of the later variant. Antisera in rats were raised previously to a complete set of overlapping, synthetic 15mer peptides following the sequence of HIV-1 SF2 gp120. These sera have now been used in neutralization and enhancement assays against viruses derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
